gptkbp:instanceOf
|
gptkb:ATC_code
|
gptkbp:ATCCode
|
N06A
|
gptkbp:class
|
gptkb:Anatomical_Therapeutic_Chemical_Classification_System
|
gptkbp:contraindication
|
hypersensitivity to active substance
bipolar disorder (without mood stabilizer)
|
gptkbp:example_drug
|
gptkb:citalopram
gptkb:escitalopram
gptkb:paroxetine
gptkb:sertraline
gptkb:doxepin
gptkb:bupropion
gptkb:venlafaxine
gptkb:desvenlafaxine
gptkb:milnacipran
gptkb:vortioxetine
gptkb:agomelatine
gptkb:amitriptyline
gptkb:imipramine
gptkb:duloxetine
gptkb:fluoxetine
gptkb:phenelzine
gptkb:tranylcypromine
gptkb:reboxetine
gptkb:clomipramine
gptkb:nortriptyline
gptkb:trimipramine
mirtazapine
maprotiline
tianeptine
|
https://www.w3.org/2000/01/rdf-schema#label
|
N06A (Antidepressants)
|
gptkbp:includes
|
gptkb:N06AX_(Other_antidepressants)
N06AA (Non-selective monoamine reuptake inhibitors)
N06AB (Selective serotonin reuptake inhibitors)
N06AG (Monoamine oxidase A inhibitors)
N06AF (Monoamine oxidase inhibitors, non-selective)
|
gptkbp:indication
|
gptkb:major_depressive_disorder
chronic pain
anxiety disorders
|
gptkbp:partOf
|
N06 (Psychoanaleptics)
|
gptkbp:regulates
|
dopamine
norepinephrine
serotonin
|
gptkbp:routeOfAdministration
|
oral
parenteral
|
gptkbp:sideEffect
|
nausea
weight gain
insomnia
sexual dysfunction
|
gptkbp:usedFor
|
treatment of depression
|
gptkbp:bfsParent
|
gptkb:N06AX21
|
gptkbp:bfsLayer
|
7
|